Grufity logoGrufity logo

Merit Medical Systems Inc Stock Research

MMSI

70.96USD+2.93(+4.31%)Market Closed

Market Summary

USD70.96+2.93
Market Closed
4.31%

MMSI Alerts

MMSI Stock Price

MMSI RSI Chart

MMSI Valuation

Market Cap

4.1B

Price/Earnings (Trailing)

54.57

Price/Sales (Trailing)

3.53

EV/EBITDA

24.74

Price/Free Cashflow

58.71

MMSI Price/Sales (Trailing)

MMSI Profitability

EBT Margin

7.18%

Return on Equity

6.51%

Return on Assets

4.48%

Free Cashflow Yield

1.7%

MMSI Fundamentals

MMSI Revenue

Revenue (TTM)

1.2B

Revenue Y/Y

5.36%

Revenue Q/Q

2.17%

MMSI Earnings

Earnings (TTM)

74.5M

Earnings Y/Y

62.04%

Earnings Q/Q

118.71%

Price Action

52 Week Range

50.4675.25
(Low)(High)

Last 7 days

2.0%

Last 30 days

-4.0%

Last 90 days

-4.5%

Trailing 12 Months

8.2%

MMSI Financial Health

Current Ratio

2.4

Debt/Equity

0.19

Debt/Cashflow

0.53

MMSI Investor Care

Shares Dilution (1Y)

1.30%

Diluted EPS (TTM)

1.29

Peers (Alternatives to Merit Medical Systems)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
104.1B
18.4B
2.26% 8.00%
44.16
5.64
7.84% 18.25%
84.2B
6.2B
-4.47% -13.27%
63.66
13.53
8.97% -22.43%
69.1B
12.7B
0.59% 12.45%
99.06
5.45
6.68% -32.95%
67.4B
19.0B
-5.16% -6.78%
41.86
3.55
-0.43% -8.78%
49.8B
5.4B
2.41% -25.12%
32.74
9.26
2.86% 1.25%
MID-CAP
7.2T
489.7M
9.34% 31.15%
82.2K
16.8K
106.51% 2464.23%
10.2B
847.1M
-3.64% 34.52%
-5.1K
12.05
13.32% -137.89%
5.2B
1.0B
-11.64% -20.31%
30.19
5.09
6.76% 24.45%
3.5B
410.9M
4.51% -3.13%
-29.82
8.43
27.29% -14.60%
2.7B
801.2M
1.13% -58.87%
-28.25
3.34
14.00% -707.69%
SMALL-CAP
1.7B
138.6M
-15.68% 29.18%
-30.43
12.07
36.62% -10.44%
1.6B
350.9M
10.38% 49.06%
-10.84
4.7
44.26% -5.42%
1.3B
820.0M
-8.35% -12.22%
25.89
1.59
10.13% 701.59%
828.4M
239.8M
0.30% 1.49%
-21.88
3.45
-4.74% -31.15%

Financials for Merit Medical Systems

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue1.3%1,1511,1361,1161,1011,075
Gross Profit1.1%519513505494485
Operating Expenses-0.6%432434429432424
  S&GA Expenses2.0%343336333339336
EBITDA6.6%171160156143-
EBITDA Margin5.3%0.15*0.14*0.14*--
Earnings Before Taxes13.7%83.0073.0069.0055.0054.00
EBT Margin12.3%0.07*0.06*0.06*--
Interest Expenses19.9%6.005.005.005.005.00
Net Income20.7%75.0062.0058.0048.0048.00
Net Income Margin19.2%0.06*0.05*0.05*--
Free Cahsflow-24.1%69.0091.0090.0093.00-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets1.9%1,6641,6331,6321,6301,648
  Current Assets5.8%529500493478482
    Cash Equivalents13.5%58.0051.0063.0054.0068.00
  Inventory7.8%266247233231222
  Net PPE1.8%383376371372372
  Goodwill0.5%360358360361362
Liabilities-4.5%520544558573608
  Current Liabilities3.6%221213196204236
  Long Term Debt-11.9%217246252243-
    LT Debt, Current0%11.0011.0010.009.008.00
    LT Debt, Non Current-9.1%187205236243234
Shareholder's Equity5.1%1,1441,0891,0731,0571,040
  Retained Earnings7.5%481447432417406
Accumulated Depreciation1.1%303300294288281
Shares Outstanding0.7%57.0057.0057.0057.0057.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-13.5%114132122124147
  Share Based Compensation-0.8%18.0018.0018.0017.0016.00
Cashflow From Investing-5.0%-57.40-54.67-45.20-40.68-37.16
Cashflow From Financing30.7%-60.26-86.98-77.80-86.43-98.43

Risks for MMSI

What is the probability of a big loss on MMSI?

68.8%


Probability that Merit Medical Systems stock will be more than 20% underwater in next one year

21.9%


Probability that Merit Medical Systems stock will be more than 30% underwater in next one year.

19.6%


Probability that Merit Medical Systems stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MMSI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Merit Medical Systems was unfortunately bought at previous high price.

Drawdowns

Returns for MMSI

Cumulative Returns on MMSI

18.6%


10-Year Cumulative Returns

21.3%


7-Year Cumulative Returns

8.6%


5-Year Cumulative Returns

26.4%


3-Year Cumulative Returns

What are the long-term rolling returns for MMSI?

FIve years rolling returns for Merit Medical Systems.

Annualized Returns

Which funds bought or sold MMSI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-19.55
24,243
4,333,240
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-92.25
-30,132,000
3,232,000
0.02%
2023-02-28
Voya Investment Management LLC
reduced
-8.77
951,732
7,746,730
0.01%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
17.46
392,000
1,230,000
0.01%
2023-02-21
KB FINANCIAL PARTNERS, LLC
new
-
3,000
3,000
-%
2023-02-21
MACQUARIE GROUP LTD
added
2.62
22,600,000
102,852,000
0.12%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
reduced
-83.84
-36,607
9,393
-%
2023-02-17
TRUIST FINANCIAL CORP
new
-
201,337
201,337
-%
2023-02-16
GHP Investment Advisors, Inc.
unchanged
-
3,124
14,124
-%
2023-02-16
MAVERICK CAPITAL LTD
added
10.02
108,319
396,319
0.01%

1–10 of 50

Latest Funds Activity

Are funds buying MMSI calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own MMSI
No. of Funds

Merit Medical Systems News

Yahoo Finance

Does Merit Medical Systems (MMSI) Have Prospects for Continued Outperformance?.

Yahoo Finance,
15 hours ago

Investor's Business Daily

The Business Journals

Zacks Investment Research

Yahoo Finance

The Advocate

Merit Medical: Q4 Earnings Snapshot.

The Advocate,
23 days ago

Zacks Investment Research

Reasons to Retain Patterson Companies (PDCO) Stock Now.

Zacks Investment Research,
24 days ago

Zacks Investment Research

Schedule 13G FIlings of Merit Medical Systems

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2023
arrowmark colorado holdings llc
4.42%
2,517,226
SC 13G/A
Feb 09, 2023
william blair investment management, llc
6.6%
3,729,980
SC 13G/A
Feb 09, 2023
vanguard group inc
11.99%
6,824,344
SC 13G/A
Jan 26, 2023
blackrock inc.
17.0%
9,670,688
SC 13G/A
Jan 20, 2023
blackrock inc.
17.0%
9,670,688
SC 13G/A
Feb 14, 2022
arrowmark colorado holdings llc
5.51%
3,111,000
SC 13G/A
Feb 10, 2022
vanguard group inc
10.16%
5,737,781
SC 13G/A
Feb 10, 2022
william blair investment management, llc
5.9%
3,357,638
SC 13G/A
Jan 27, 2022
blackrock inc.
14.8%
8,334,516
SC 13G/A
Jan 25, 2022
blackrock inc.
14.8%
8,334,516
SC 13G/A

MMSI Fair Value

Recent SEC filings of Merit Medical Systems

View All Filings
Date Filed Form Type Document
Mar 16, 2023
4
Insider Trading
Mar 15, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 10, 2023
4
Insider Trading
Mar 08, 2023
4
Insider Trading
Mar 07, 2023
4
Insider Trading
Mar 03, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading

Latest Insider Trading transactions for MMSI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-14
Voigt Michel James
sold
-136,620
68.31
-2,000
chief human resources officer
2023-03-13
Lloyd Brian G.
gifted
-
-
-1,450
chief legal officer, secretary
2023-03-08
Ward Lynne
acquired
68,920
34.46
2,000
-
2023-03-08
Ward Lynne
sold
-772,789
66.706
-11,585
-
2023-03-07
ANDERSON A SCOTT
gifted
-
-
-3,000
-
2023-03-06
ANDERSON A SCOTT
sold
-1,001,160
66.744
-15,000
-
2023-03-06
ANDERSON A SCOTT
acquired
438,000
29.2
15,000
-
2023-03-03
Parra Raul Jr.
sold
-71,610
70.00
-1,023
cfo and treasurer
2023-03-02
LAMPROPOULOS FRED P
sold
-1,339,620
69.859
-19,176
president and ceo
2023-03-02
Parra Raul Jr.
acquired
226,260
37.71
6,000
cfo and treasurer

1–10 of 50

Fred P. Lampropoulos
6450
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Net sales$ 1,150,981$ 1,074,751$ 963,875
Cost of sales631,882589,418562,698
Gross profit519,099485,333401,177
Operating expenses:   
Selling, general and administrative342,525335,690297,724
Research and development75,51071,24757,537
Legal settlement 10,03618,684
Impairment charges2,2194,28336,504
Contingent consideration expense (benefit)4,6113,161(7,960)
Acquired in-process research and development6,671 250
Total operating expenses431,536424,417402,739
Income (loss) from operations87,56360,916(1,562)
Other income (expense):   
Interest income439769604
Interest expense(6,339)(5,261)(9,994)
Other income (expense) - net966(2,507)(2,279)
Total other expense - net(4,934)(6,999)(11,669)
Income (loss) before income taxes82,62953,917(13,231)
Income tax expense (benefit)8,1135,463(3,388)
Net income (loss)$ 74,516$ 48,454$ (9,843)
Earnings (loss) per common share   
Basic (in dollars per share)$ 1.31$ 0.86$ (0.18)
Diluted (in dollars per share)$ 1.29$ 0.84$ (0.18)
Weighted average shares outstanding   
Basic (in shares)56,80656,14555,434
Diluted (in shares)57,67157,35955,434

MMSI Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 58,408$ 67,750
Trade receivables - net of allowance for credit losses - 2022 - $8,423 and 2021 - $6,767164,677152,301
Other receivables12,99217,763
Inventories265,991221,922
Prepaid expenses and other current assets22,32416,149
Prepaid income taxes3,9133,550
Income tax refund receivables7792,777
Total current assets529,084482,212
Property and equipment:  
Land and land improvements25,94025,287
Buildings189,148190,044
Manufacturing equipment299,089277,976
Furniture and fixtures61,12861,446
Leasehold improvements49,67346,341
Construction-in-progress61,26951,182
Total property and equipment686,247652,276
Less accumulated depreciation(303,271)(280,618)
Property and equipment - net382,976371,658
Other assets:  
Goodwill359,821361,741
Deferred income tax assets6,5996,080
Right-of-use operating lease assets65,26265,913
Other assets44,35241,421
Total other assets751,906794,424
Total assets1,663,9661,648,294
Current liabilities:  
Trade payables68,50455,624
Accrued expenses123,189159,014
Current portion of long-term debt11,2508,438
Short-term operating lease liabilities11,00510,668
Income taxes payable6,6972,536
Total current liabilities220,645236,280
Long-term debt186,759234,397
Deferred income tax liabilities18,46231,503
Long-term income taxes payable347347
Liabilities related to unrecognized tax benefits1,912932
Deferred compensation payable15,26418,111
Deferred credits1,7081,815
Long-term operating lease liabilities59,73661,526
Other long-term obligations14,73623,584
Total liabilities519,569608,495
Commitments and contingencies
Stockholders' equity:  
Preferred stock - 5,000 shares authorized as of December 31, 2022 and December 31, 2021; no shares issued00
Common stock, no par value; 100,000 shares authorized; issued and outstanding as of December 31, 2022 - 57,306 and December 31, 2021 - 56,570675,174641,533
Retained earnings480,773406,257
Accumulated other comprehensive loss(11,550)(7,991)
Total stockholders' equity1,144,3971,039,799
Total liabilities and stockholders' equity1,663,9661,648,294
Developed technology  
Other assets:  
Intangible assets237,522276,833
Other  
Other assets:  
Intangible assets$ 38,350$ 42,436